These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31396394)

  • 21. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans.
    Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS
    J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JMM Profile:
    Bonis BM; Hunter RC
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35587447
    [No Abstract]   [Full Text] [Related]  

  • 23. AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.
    Pongchaikul P; Santanirand P; Antonyuk S; Winstanley C; Darby AC
    FEMS Microbiol Lett; 2020 Jul; 367(14):. PubMed ID: 32592387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
    Shin KS; Han K; Lee J; Hong SB; Son BR; Youn SJ; Kim J; Shin HS
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):215-20. PubMed ID: 16260111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achromobacter xylosoxidans in hospital environments: still waters run deep!
    Marion-Sanchez K; Olive C; Platon MG; Cesarine M; Derancourt C; Pailla K
    Trans R Soc Trop Med Hyg; 2020 Jun; 114(6):470-472. PubMed ID: 31836888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.
    Bador J; Amoureux L; Blanc E; Neuwirth C
    Antimicrob Agents Chemother; 2013 Jan; 57(1):603-5. PubMed ID: 23089757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis.
    Khademi SMH; Gabrielaite M; Paulsson M; Knulst M; Touriki E; Marvig RL; Påhlman LI
    mSystems; 2021 Jun; 6(3):e0052321. PubMed ID: 34184916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France.
    Neuwirth C; Freby C; Ogier-Desserrey A; Perez-Martin S; Houzel A; Péchinot A; Duez JM; Huet F; Siebor E
    Emerg Infect Dis; 2006 Nov; 12(11):1737-9. PubMed ID: 17283625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and use of an efficient system for random mariner transposon mutagenesis to identify novel genetic determinants of biofilm formation in the core Enterococcus faecalis genome.
    Kristich CJ; Nguyen VT; Le T; Barnes AM; Grindle S; Dunny GM
    Appl Environ Microbiol; 2008 Jun; 74(11):3377-86. PubMed ID: 18408066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
    Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
    Mathy V; Grohs P; Compain F
    J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dlt genes play a role in antimicrobial tolerance of Streptococcus mutans biofilms.
    Nilsson M; Rybtke M; Givskov M; Høiby N; Twetman S; Tolker-Nielsen T
    Int J Antimicrob Agents; 2016 Sep; 48(3):298-304. PubMed ID: 27502751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the
    Le Goff M; Vastel M; Lebrun R; Mansuelle P; Diarra A; Grandjean T; Triponney P; Imbert G; Gosset P; Dessein R; Garnier F; Durand E
    Front Cell Infect Microbiol; 2022; 12():859181. PubMed ID: 35782124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.
    Bador J; Amoureux L; Duez JM; Drabowicz A; Siebor E; Llanes C; Neuwirth C
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4912-4. PubMed ID: 21807978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes.
    Nielsen SM; Nørskov-Lauritsen N; Bjarnsholt T; Meyer RL
    Microorganisms; 2016 Sep; 4(3):. PubMed ID: 27681927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediastinitis superinfected by Achromobacter xylosoxidans. A case report.
    Marion-Sanchez K; Lion F; Olive C; Cailleaux G; Roques F
    J Infect Chemother; 2018 Dec; 24(12):987-989. PubMed ID: 29895453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of Achromobacter xylosoxidans highly resistant to aminoglycoside antibiotics.
    Nakamoto S; Goda N; Hayabuchi T; Tamaki H; Ishida A; Suzuki A; Nakano K; Yui S; Katsumata Y; Yamagami Y; Burioka N; Chikumi H; Shimizu E
    Jpn J Antibiot; 2016 Apr; 69(2):113-8. PubMed ID: 27544979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.